COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 656.2 | 9 | 0238-0516 | 369.98 | 516.93 | 269 | 64.18 | 0.821 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2133.8 | 9 | 0239-0519 | 104.22 | 518.97 | 321 | 67.26 | 0.892 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2871.2 | 9 | 0240-0525 | 570.22 | 526.36 | 302 | 65.94 | 0.873 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 3067.9 | 9 | 0241-0528 | 304.28 | 527.73 | 282 | 63.36 | 0.883 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2278.2 | 9 | 0242-0532 | 817.06 | 532.15 | 301 | 66.18 | 0.864 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 696.0 | 9 | 0243-0529 | 424.39 | 528.53 | 175 | 47.94 | 0.957 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 389.6 | 9 | 0244-0536 | 692.32 | 536.35 | 300 | 71.01 | 0.748 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 387.5 | 9 | 0245-0535 | 203.65 | 535.32 | 324 | 70.77 | 0.813 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1619.6 | 9 | 0246-0534 | 332.49 | 534.09 | 240 | 59.60 | 0.849 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1908.1 | 9 | 0247-0535 | 479.98 | 535.04 | 241 | 57.94 | 0.902 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 3216.4 | 9 | 0248-0535 | 624.18 | 535.37 | 228 | 54.53 | 0.964 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1670.8 | 9 | 0249-0541 | 520.93 | 541.71 | 289 | 66.08 | 0.832 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 619.9 | 9 | 0250-0540 | 436.99 | 540.78 | 196 | 51.94 | 0.913 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2223.6 | 9 | 0251-0542 | 849.90 | 542.58 | 274 | 61.36 | 0.915 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1992.0 | 9 | 0252-0547 | 578.88 | 546.35 | 334 | 73.26 | 0.782 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 904.7 | 9 | 0253-0547 | 64.50 | 546.90 | 227 | 56.77 | 0.885 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2149.1 | 9 | 0254-0548 | 272.23 | 548.62 | 433 | 82.67 | 0.796 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1912.5 | 9 | 0255-0549 | 125.58 | 549.29 | 309 | 65.60 | 0.902 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1884.5 | 9 | 0256-0552 | 634.80 | 553.72 | 295 | 69.01 | 0.778 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2287.6 | 9 | 0257-0554 | 757.50 | 554.76 | 286 | 61.94 | 0.937 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 422.7 | 9 | 0258-0558 | 555.44 | 558.53 | 254 | 60.77 | 0.864 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 322.8 | 9 | 0259-0560 | 24.96 | 560.43 | 200 | 53.70 | 0.872 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1765.4 | 9 | 0260-0562 | 697.90 | 561.96 | 263 | 64.77 | 0.788 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1736.9 | 9 | 0261-0563 | 849.83 | 563.63 | 267 | 62.77 | 0.852 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2475.5 | 9 | 0262-0566 | 598.76 | 565.95 | 287 | 64.18 | 0.875 |